1201 GMT - Tate & Lyle is likely to face some hurdles in meeting its medium term targets, Morgan Stanley analysts write in a note. The provider of food-and-drink ingredients' ability to reach its midterm targets remain uncertain after Tyson Foods said it would drop sucralose from U.S. branded products, with the risk that more consumer packaged goods could follow. This could potentially weigh on the share price as sucralose represents around 9% of the company's group sales, they say. "With the level of growth now incrementally into question... investors can find superior investment opportunities elsewhere," they add. The U.S. bank downgrades its stock recommendation to underweight from equal-weight and its target price to 500 pence from 590 pence. Tate & Lyle shares are down 6.1% at 469.40 pence. (najat.kantouar@wsj.com)

(END) Dow Jones Newswires

September 22, 2025 08:01 ET (12:01 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.